Dec 2009
Time for pharma marketing to take it up in 2010
Dec/30/2009 07:09 Filed in: Working
in the drug industry #in
2010 is almost
here and a lot of people will be trying to get
back into the groove of going back to work after
a lengthy holiday break. Will it be more of the
same ol' same ol' or will there be an effort to
think of new ways to interact with empowered
patients and consumers who mistrust big business
? Here are some ways to take it up a notch in
2010.
Read More...
Read More...
|
2010: Where does pharma marketing go from here ?
Dec/27/2009 10:38 Filed in: DTC
Marketing
There's no doubt
that consumers have changed their behavior as a
result of the recent recession. Some marketers
believe that that it's temporary but I think the
Internet and mistrust in big pharma is redefining
how consumers approach and think about
healthcare. The key issue now ? Will DTC
marketers and the drug industry change the way
they market to consumers or will they continue
down the same path as before as the wait for the
FDA to issue guidelines ? Click here to
download my presentation called
"Where do we go from here"
Read More...
Read More...
Who do consumers trust when it comes to healthcare?
Dec/21/2009 06:20 Filed in: Trust and
healthcare
Mobile marketing, the next wave to come crashing to shore
Dec/18/2009 06:03 Filed in: #mobilemarketing
What do eHealth consumers want from social media?
Dec/17/2009 06:00 Filed in: Social
Media
Read More...
A search engine just for health ?
Dec/16/2009 01:36 Filed in: Search
Marketing & Pharma
One of the
issues that consistently comes up when I do
research with consumers on the Internet is that
they are often overwhelmed with search results.
Where do they go? What is credible? Where do they
start? It looks like a new website that launched
today finally solved that problem. Welcome
to Healthbase
Read More...
Read More...
How should big pharma handle newly reported side effects ?
Dec/14/2009 04:47 Filed in: Drug
Industry & The Media
Pay as you live health models ?
Dec/11/2009 03:04 Filed in: Cost of
healthcare
If your agency is telling you to spend more money on search, run away !
Dec/10/2009 06:52 Filed in: Search
Marketing & Pharma
I usually like
the research that Pew Internet publishes but the
report on search on health is "duh 101"; We've
found consistently in our health surveys that a
general search is the first stop for health
consumers on the Internet," Fox says. Fox says
half of online health queries are for someone
else. And women are more likely to conduct health
searches than men. If your agency is telling you
to spend more money on search because of data
like this you need to run away because they
should be saying "we've found a way to maximize
your search dollars while spending less".
Read More...
iPhone Application from Sanofi Aventis maybe just the start of new marketing opportunities in DTC
Dec/09/2009 06:08 Filed in:
Mobile DTC Marketing Opportunities
Imagine you're
on the road and trying to eat right.
Sanofi's GoMeals™ makes it
easy to access nutritional information, find
restaurants and keep track of your food
intake. If you have a health condition like
diabetes, knowing information like calories,
fats and carbs can be critical. GoMeals was
developed to help consumers get the
information they need to make better meal
choices at home or on the go. This is a great
app but this is just the start of a lot of
mobile tools to come if pharma can prepare for
the future and anticipate the opportunities of
mobile apps plus the Apple tablet.
Read More...
$30,000 a month for a cancer treatment that may not prolong life
Dec/08/2009 05:54 Filed in: Cost of
healthcare
The price of the
new drug, called Folotyn, is at least triple that
of other drugs that critics have said are too
expensive for the benefits they offer to
patients. The cost is $30,000 a month and while
drug companies have the right to set prices to
recoup costs the cost of this product is surely
going to bring more unneeded attention to the
drug industry and their pricing tactics.
Read More...
Drug companies don't have the luxury of waiting for the FDA to issue guidelines on marketing
Dec/07/2009 10:58 Filed in: DTC
Environment
So what's wrong
with this picture? Drug companies are going to
see a lot of big named brands come off patent and
in addition it seems that the $80 billion of
concessions via the new healthcare bill is not
enough for Democrats who want to squeeze the
industry like a sponge. So rather than ramp up
marketing as they realize that empowered patients
are consumers of healthcare they are waiting for
an ever cautious Federal agency to issue
guidelines that maybe outdated as soon as they
are issued?
Read More...
Regulatory restraints = ignorance of social media and empowered consumers Why DTC marketing is in a funk
Dec/07/2009 08:23 Filed in: Social
Media
"The
concept and value of the social medium as this
unconstrained exchange is not consistent with the
regulatory constraints," said Chris
Kuenne, CEO of Rosetta Stone. Excuse me but that
is wrong on so many levels and shows why the
pharma industry is so behind the times when it
comes to DTC marketing.
Read More...
Read More...
What's really holding back DTC marketing? Hint: Let's have a meeting to talk about it
Dec/06/2009 04:43 Filed in: Working
in the drug industry
If social media is not the answer, what's the future of DTC ?
Dec/06/2009 09:39 Filed in: Where
do we go from here?
Finally
business
publications and
marketing people are beginning
to realize that social
media, alone, is
not the answer to the riddle of empowered
consumers. The fact that so many consumers
don't trust the FDA or the the drug industry
is just one of the many symptoms that DTC
marketing is one very sick patient. So what
can marketers do to make DTC marketer relevant
again?
Read More...
Read More...
Doctors are increasingly concerned that the sales pitches from drug reps are not giving them the full story
Dec/04/2009 06:46 Filed in: HCP
Marketing
42,000 and
counting. That's the number of jobs that have
been shed by big pharma this year, mostly in the
sales force. Are there more to come? Well, if big
pharma wants to maintain a nice healthy profit
margin (the biggest by the way of ANY industry)
they are going to have to continue to cut costs
and at a time when the sales force is becoming
less effective I expect a lot more cuts in that
area.
Read More...













